Correlation Between Gamida Cell and Werewolf Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gamida Cell and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gamida Cell and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gamida Cell and Werewolf Therapeutics, you can compare the effects of market volatilities on Gamida Cell and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gamida Cell with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gamida Cell and Werewolf Therapeutics.
Diversification Opportunities for Gamida Cell and Werewolf Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Gamida and Werewolf is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Gamida Cell and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Gamida Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gamida Cell are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Gamida Cell i.e., Gamida Cell and Werewolf Therapeutics go up and down completely randomly.
Pair Corralation between Gamida Cell and Werewolf Therapeutics
If you would invest 205.00 in Werewolf Therapeutics on September 4, 2024 and sell it today you would lose (9.00) from holding Werewolf Therapeutics or give up 4.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 0.34% |
| Values | Daily Returns |
Gamida Cell vs. Werewolf Therapeutics
Performance |
| Timeline |
| Gamida Cell |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Werewolf Therapeutics |
Gamida Cell and Werewolf Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gamida Cell and Werewolf Therapeutics
The main advantage of trading using opposite Gamida Cell and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gamida Cell position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.| Gamida Cell vs. BioLineRx | Gamida Cell vs. Ardelyx | Gamida Cell vs. Lexicon Pharmaceuticals | Gamida Cell vs. Seres Therapeutics |
| Werewolf Therapeutics vs. Candel Therapeutics | Werewolf Therapeutics vs. Cingulate Warrants | Werewolf Therapeutics vs. Unicycive Therapeutics | Werewolf Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |